Document is current

Any future updates will be listed below

Identifying drug targets and evaluating KLK3-targeted inhibitors for prostate cancer using in-silico and in-vitro approaches

Crossref DOI link: https://doi.org/10.1007/s12032-025-02896-x

Published Online: 2025-09-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark